Gilead Sciences, Inc.
GILD
$148.95
$5.183.60%
NASDAQ
Recommendation
Dividend Power Score
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
P/E (TTM)
EPS (TTM)
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 2.00% | 9.72% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 2.01% | 9.70% | |||
| Cost of Revenue | 3.25% | 4.53% | |||
| Gross Profit | 1.69% | 11.09% | |||
| SG&A Expenses | 31.43% | -0.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.64% | -1.25% | |||
| Operating Income | -15.71% | 26.72% | |||
| Income Before Tax | -42.93% | 49.96% | |||
| Income Tax Expenses | -117.83% | 25.85% | |||
| Earnings from Continuing Operations | -28.47% | 55.71% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -28.47% | 55.71% | |||
| EBIT | -15.71% | 26.72% | |||
| EBITDA | -13.12% | 21.25% | |||
| EPS Basic | -28.42% | 55.96% | |||
| Normalized Basic EPS | -16.14% | 29.61% | |||
| EPS Diluted | -28.41% | 55.77% | |||
| Normalized Diluted EPS | -16.14% | 29.50% | |||
| Average Basic Shares Outstanding | -0.08% | -0.16% | |||
| Average Diluted Shares Outstanding | -0.08% | -0.08% | |||
| Dividend Per Share | -- | 0.00% | |||
| Payout Ratio | 0.38% | -0.35% | |||